The recently demonstrated inhibition of neurodegenerative genes by PRC2 and antagonism between PRC2 and HMGN1 can potentially contribute to the upregulation of the pro-apoptotic genes in DS and enhanced neurodegeneration. The gene discussed is HMGN1; the disease is Dravet syndrome.